Re: Slow Response Here Too!

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Slow Response Here Too!

in response to

Re: Slow Response Here Too!

SanFrancisco99

posted on Mar 01, 2017 05:50PM

From the 15 Nov 2016 Notice of Meeting and Management Information Circular posted on SEDAR on Pg6 Eastern owns 38.1% of Zenith Capital Corp. NGN has just over 10% as well.